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This article is part of the the PLoS
Medicine series on Big Food.
Today we launch a major new series on
‘‘Big Food’’ in the PLoS Medicine Maga-
zine. Over three weeks beginning 19 June
2012 we will publish seven articles that
examine the activities and influence of the
food and beverage industry in the health
arena. These articles were commissioned
by the senior Magazine editor (JC) under
the guidance of our series guest editors
Marion Nestle of New York University
and David Stuckler of Cambridge Univer-
sity, and together they represent a multi-
disciplinary approach to exploring the role
in health of Big Food, which we define as
the multinational food and beverage
industry with huge and concentrated
market power [1].
Industry in health has long fascinated
PLoS Medicine but our focus on Big Food is
new. Food, unlike tobacco and drugs, is
necessary to live and is central to health
and disease. And yet the big multinational
food companies control what people
everywhere eat, resulting in a stark and
sick irony: one billion people on the planet
are hungry while two billion are obese or
overweight [2].
The time is ripe for PLoS Medicine to
shine a light on Big Food. Foremost, large
food and beverage companies now have
an undeniably influential presence on the
global health stage. Whether it’s food
company executives providing expertise
at major conferences and high-level UN
meetings (e.g., [3]) or major global health
funders lecturing on what nongovernmen-
tal organizations can learn from Coca-
Cola [4], the perspectives and experiences
of Big Food are shaping the field of global
health. At the same time that their
expertise is elevated in global health
debates, food companies are rebranding
themselves as ‘‘nutrition companies,’’ of-
fering business acumen and knowledge in
food science and distribution, and assert-
ing authority over solutions to problems
not just of food production but of
malnutrition, obesity, and even poverty.
The legitimization of food companies as
global health experts is further fueled by
the growing number of private-public
partnerships with public health organiza-
tions [5], ostensibly designed to foster
collaborative action to improve people’s
health and wellbeing. And yet food
companies’ primary obligation is to drive
profit by selling food. Why does the global
health community find this acceptable and
how do these conflicts of interest play out?
Indeed, while problems of obesity and
associated disease are dominating discus-
sions and debates in health around the
world, there’s a concomitant gulf of critical
perspectives on the food industry’s role
and competing interests. Despite PLoS
Medicine’s longstanding interest in the
tobacco, pharmaceutical, and other indus-
tries in health, for example, we have paid
relatively little attention to the activities
and influence of food and beverage
companies: just two articles in 2007 [6,7]
and a recent editorial on the alcohol
industry [8]. Searching PubMed, only an
additional seven articles examining any
aspect of the food industry have been
published in the major general medical
journals over the past 10 years.
According to Marion Nestle, these
issues have been known and discussed
(though not always acted upon) within the
nutrition community for decades, which
makes the lack of attention in the medical
literature even more disappointing. In fact,
Nestle’s 2002 book Food Politics: How the
Food Industry Influences Nutrition and Health is
prescient in documenting a laundry list of
Big Food misdeeds that are only receiving
more widespread attention now: aggres-
sive lobbying of regulators and govern-
ments, co-opting domestic and interna-
tional nutrition experts, deceptive and
illegal marketing to children, tactical
targeting of minorities and emerging
economies, and undisclosed conflicts of
interest, among others, resulting in her
conclusion 10 years ago that the food
industry ‘‘plays politics better than any-
one’’ [9]. More recent evidence confirms
that Big Food and Big Alcohol are
mimicking (and learning from) the tactics
of Big Tobacco [8,10–13]. In recognition,
a bold move by Journal of Public Health
Policy discourages studies of individual
eating and activity [14,15] because, as
the editors state, they ‘‘have come to
believe that research studies concentrating
on personal behavior and responsibility as
causes of the obesity epidemic do little but
offer cover to an industry seeking to
downplay its own responsibility.’’
The PLoS Medicine series on Big Food is
a ‘‘sampler,’’ offering perspectives on
select topics relevant to how the food
industry operates in health. In this first
week the guest editors lay out a back-
ground and three competing views of how
public health professionals can respond
[1], and Lori Dorfman and her colleagues
[16] compare soda companies’ corporate
social responsibility (CSR) campaigns with
those of the tobacco industry, demonstrat-
ing how CSR deftly shifts responsibility for
overconsumption from corporations to
individuals, forestalls regulation, and pro-
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quent weeks we will publish analyses of the
rapid rise of Big Food sales in developing
countries, an essay on food sovereignty
and who holds power over food, and two
perspectives from South America and
Africa on the displacement of traditional
diets by the incursion of multinational
food companies. We decided not to
provide a forum for the industry to offer
a perspective on their role in global health,
since this point of view has been covered
many times before [17–20] and fails to
acknowledge their role in subverting the
public health agenda, thus ignoring the
deeper issues that this series aims to
uncover.
While our series does include perspec-
tives from several countries around the
world (including Brazil, South Africa, the
UK, and the US), our series is not as
regionally diverse as would be ideal. When
commissioning we had a difficult time
finding authors in the developing world
who had not already established links with
food companies (thus disqualifying them
from contributing to the series, per our
Magazine competing interests policy),
which might be more evidence for con-
cerns about co-opting of international
nutrition experts.
The series is not comprehensive in
highlighting all the relevant issues but
should signal to readers our interest in
considering further original research and
commentary on additional areas to do
with the food industry in health, including
marketing to children, litigation, regulato-
ry efforts, the impact of agriculture
systems, solutions to obesity and noncom-
municable diseases, and the growth and
spread of markets in emerging economies.
Clearly issues of nutrition and diet are key
to human health and to the health of the
planet. We look forward to continuing to
be part of the dialogue and invite readers
to join the debate via twitter (hashtag
#plosmedbigfood) and to comment on the
articles, which will be published over three
weeks and collected at http://www.
ploscollections.org/bigfood.
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